Alzheimers Drug
![Alzheimers Drug](/upload/8139924/1c494523392949c9b3f7c802f834e174--0--cb347e2f4036455a9be19bea9936d076.jpg?w=1000&original=)
Alzheimers Drug
This image provided by Eli Lilly shows the company's new Alzheimer’s drug Kisunla. The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday, July 2, 2024 for mild or early cases of dementia caused by Alzheimer’s. (Eli Lilly and Company via AP)
Абонирайте се
Влезте във Вашата БТА
![Alzheimers Drug](/upload/8139960/ac1ea006e63743249021eb9ef015a497--0--f565184ffcb2480b83cc776f40726b8d.jpg?w=1000&original=)
Alzheimers Drug
This image provided by Eli Lilly shows the company's new Alzheimer’s drug Kisunla. The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday, July 2, 2024 for mild or early cases of dementia caused by Alzheimer’s. (Eli Lilly and Company via AP)
Абонирайте се
Влезте във Вашата БТА
Избиране на снимки
Моля потвърдете избраните снимки. Това действие не е свързано с плащане. Ако продължите, избраните снимки ще бъдат извадени от баланса на вашите активни абонаментни пакети.
Изтегляне на снимка
Моля потвърдете изтеглянето на снимката/ите
![Alzheimers Drug](/upload/8139924/1c494523392949c9b3f7c802f834e174--0--cb347e2f4036455a9be19bea9936d076.jpg?w=270&h=180)
![Alzheimers Drug](/upload/8139960/ac1ea006e63743249021eb9ef015a497--0--f565184ffcb2480b83cc776f40726b8d.jpg?w=270&h=180)
This image provided by Eli Lilly shows the company's new Alzheimer’s drug Kisunla. The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday, July 2, 2024 for mild or early cases of dementia caused by Alzheimer’s. (Eli Lilly and Company via AP)